We specialise in the delivery of large-volume formulations and understand the constraints, and trade-offs, of large-volume, high-viscosity injectors and devices in order to rapidly bring solutions to market.

We leverage our expertise in human factors, biomechanics, and engineering to deliver connected drug delivery injectors, inhalers, and other devices that can fit into large and complex digital health ecosystems and patient workflows.

We understand the value of adherence models to drive sustainable innovation. At TTP, we use complex behavioural science to underpin our adherence model in order to create better interventions, design future disease management solutions, predictive models, and valuable decision-making tools.

TTP's adherence modelling provides clients with holistic thinking and insight into their connected device developments for sustainable innovation.